News

Soliris® (eculizumab), the first TGA-approved medication for NMOSD, has not been recommended for listing on the PBS.

New imaging data shows sustained improvement in disability and increases in myelin density in the brain following an experimental treatment for progressive MS.

CEO Rohan Greenland gives an update on the MS Australia activities for December, focusing on the year ahead for MS Australia.

We look back on the enormous milestones reached in 2021 thanks to the Kiss Goodbye to MS community. Thank you for continuing to accelerate our superpower – MS research.

A recent study from regional NSW is the first to assess if the NDIS package allocated to people with MS matches the level of disability measured by a formal neurological assessment. 

A new study of brain tissue has found that immune cells derived from blood immune cells, attack myelin in the very early stages of MS.

MS Australia National Advocate Erin Brady reflects on International Day of People with Disability in a post-pandemic world.

Our Kiss Goodbye to MS ambassadors say thank you to the fantastic MS community by sharing their very own thank you letters.

MS researchers have investigated whether a naturally occurring molecule, which some DMTs mimic, has the capacity to promote myelin repair.

CEO Rohan Greenland gives an update on the MS Australia activities for November, focusing on MS Australia's 2021 Prime Award nomination.

New research funded by MS Australia has shown how UV light traps immune cells in the lymph nodes, similar to the action of some MS therapies.

MS Australia has funded seven new innovative MS research projects totalling nearly $150,000 in this year’s first round of incubator grants.

A study has followed the progress of over 500 people with MS who have undergone AHSCT for up to 5 years after the procedure.

MS Australia Chair of the John Studdy Award panel, Sharlene Brown, is delighted to announce the 2020 John Studdy Award winner is Mr Ian Pennell AM.

There have been recent positive steps forward for people with MS considering AHSCT. Read the current thinking towards AHSCT for people with MS.

CEO Rohan Greenland gives an update on the MS Australia activities for October, focusing on the world's largest MS research conference ECTRIMS and the importance of conferences in shaping the future of MS.

In 2015 Sarah's life changed completely when she was diagnosed with multiple sclerosis, she is now on a mission to raise funds to power MS research.

The International Progressive MS Alliance has recently highlighted that very little progress has been made in treating and understanding MS fatigue.